Last $60.06 USD
Change Today +0.18 / 0.30%
Volume 4.3M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 2:49 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Elizabeth Adkins Czerepak

Former Other Professional, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 27 board members in 3 different organizations across 12 different industries.

See Board Relationships
58--

Background*

Ms. Elizabeth Adkins Czerepak served as the Chief Financial Officer of Cancer Genetics, Inc. from January 24, 2011 to March 31, 2014 and also served as its Principal Accounting Officer until March 2014. Ms. Czerepak Co-Founded BIOptima Advisors in May 2009. She was a Managing Partner at Bear Stearns Health Innoventures Management, L.L.C. She is employed at Bear Stearns Asset Management Inc. Ms. Czerepak is the General Partner of the funds comprising the Bear Stearns ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

Director
Former Director
Director
Director
Former Director
2003-2005
Former Director, Member of Compensation Committee and Member of Nominating & Governance Committee
2004-2007
Former Director
2007-2008
Former Director, Member of Audit Committee and Member of Governance & Nominating Committee

Education*

MBA
Rutgers, The State University of New Jersey
BA
Marshall University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $60.06 USD +0.18

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.